Literature DB >> 30977428

Advances in spirometry testing for lung function analysis.

Agnaldo José Lopes1,2.   

Abstract

Introduction: Spirometry, the most common lung function test, is used to evaluate individuals with respiratory complaints or known respiratory disease. However, its underutilization and the misinterpretation of its parameters are causes for concern. Areas covered: This review describes new spirometry-derived metrics, new reference equations, recent recommendations for presentation of results, recent spirometry-based prevalence studies, and technological advances in spirometry equipment. Expert opinion: The underutilization of spirometry can be overcome by increasing access to portable, hand-held, and user-friendly spirometers, together with strategies that increase awareness of the importance of spirometry. New metrics derived from spirometry, together with traditional spirometric criteria, can identify individuals with structural lung disease and respiratory morbidity. Some problems with the reference equations were solved by the Global Lung Function Initiative (GLI), which covers a wider age range and more ethnic groups and provides limits of normality using the z-score. Despite these advantages, the GLI equations lack data from large populations (especially those from Africa, South Asia, and Latin America) and greater representation of older people. Another disadvantage attributed to the GLI is the lack of predicted values for peak expiratory flow and other airflows, limiting the interpretation of the maximal expiratory flow-volume curve.

Entities:  

Keywords:  Spirometry; asthma; chronic obstructive pulmonary disease; education; new technologies; pulmonary function; reference equations

Mesh:

Year:  2019        PMID: 30977428     DOI: 10.1080/17476348.2019.1607301

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  2 in total

Review 1.  Flow Cytometry: From Experimental Design to Its Application in the Diagnosis and Monitoring of Respiratory Diseases.

Authors:  Julio Flores-Gonzalez; Juan Carlos Cancino-Díaz; Leslie Chavez-Galan
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

2.  A Physiotherapy Treatment Plan for Post-COVID-19 Patients That Improves the FEV1, FVC, and 6-Min Walk Values, and Reduces the Sequelae in 12 Sessions.

Authors:  Silvia Denise Ponce-Campos; Juan Manuel Díaz; Daniela Moreno-Agundis; Ana Laura González-Delgado; Paulina Andrade-Lozano; Francisco Javier Avelar-González; Eduardo Hernández-Cuellar; Fernando Torres-Flores
Journal:  Front Rehabil Sci       Date:  2022-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.